JP5992324B2 - 脂肪酸モノグリセリド組成物 - Google Patents

脂肪酸モノグリセリド組成物 Download PDF

Info

Publication number
JP5992324B2
JP5992324B2 JP2012500982A JP2012500982A JP5992324B2 JP 5992324 B2 JP5992324 B2 JP 5992324B2 JP 2012500982 A JP2012500982 A JP 2012500982A JP 2012500982 A JP2012500982 A JP 2012500982A JP 5992324 B2 JP5992324 B2 JP 5992324B2
Authority
JP
Japan
Prior art keywords
composition
composition according
present
amount
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012500982A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012521351A5 (enExample
JP2012521351A (ja
Inventor
ジョン、レン
バリー、ハント
エドワード、シャ
Original Assignee
スティーフェル ラボラトリーズ インコーポレイテッド
スティーフェル ラボラトリーズ インコーポレイテッド
スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド
スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5992324(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by スティーフェル ラボラトリーズ インコーポレイテッド, スティーフェル ラボラトリーズ インコーポレイテッド, スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド, スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド filed Critical スティーフェル ラボラトリーズ インコーポレイテッド
Publication of JP2012521351A publication Critical patent/JP2012521351A/ja
Publication of JP2012521351A5 publication Critical patent/JP2012521351A5/ja
Application granted granted Critical
Publication of JP5992324B2 publication Critical patent/JP5992324B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012500982A 2009-03-20 2010-03-19 脂肪酸モノグリセリド組成物 Active JP5992324B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US61/202,635 2009-03-20
US21331309P 2009-05-28 2009-05-28
US61/213,313 2009-05-28
PCT/US2010/027905 WO2010108060A1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Publications (3)

Publication Number Publication Date
JP2012521351A JP2012521351A (ja) 2012-09-13
JP2012521351A5 JP2012521351A5 (enExample) 2012-12-06
JP5992324B2 true JP5992324B2 (ja) 2016-09-14

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012500982A Active JP5992324B2 (ja) 2009-03-20 2010-03-19 脂肪酸モノグリセリド組成物

Country Status (15)

Country Link
US (2) US20110305646A1 (enExample)
EP (1) EP2408299B1 (enExample)
JP (1) JP5992324B2 (enExample)
KR (1) KR101506369B1 (enExample)
CN (1) CN102368904B (enExample)
AU (1) AU2010226476B2 (enExample)
BR (1) BRPI1014529A2 (enExample)
CA (1) CA2756047C (enExample)
CL (1) CL2011002302A1 (enExample)
EA (1) EA022569B1 (enExample)
ES (1) ES2437395T3 (enExample)
IL (1) IL214887A (enExample)
MX (1) MX2011009781A (enExample)
PL (1) PL2408299T3 (enExample)
WO (1) WO2010108060A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US20160166491A1 (en) * 2014-03-26 2016-06-16 Mandom Corporation Deodorant composition and deodorant agent
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
EP3468544A2 (en) * 2016-06-13 2019-04-17 Vyome Therapeutics Limited Synergistic antifungal compositions and methods thereof
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
AU2020408342B2 (en) * 2019-12-20 2024-02-22 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
FI912955A7 (fi) * 1990-06-25 1991-12-26 Res Foundation For Mental Hygiene Antimikrobiset rasvahappokoostumukset
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
DE19540465A1 (de) 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
PL357111A1 (en) * 2000-02-16 2004-07-12 Bentley Pharmaceuticals, Inc. Pharmaceutical composition
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
KR20050030205A (ko) * 2002-07-22 2005-03-29 시바 스폐셜티 케미칼스 홀딩 인코포레이티드 공중합체 및 개인 케어 조성물에의 용도
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
EP1633818A2 (en) * 2003-04-18 2006-03-15 MERCK PATENT GmbH Antimicrobial pigments
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
AU2009240389A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections

Also Published As

Publication number Publication date
ES2437395T3 (es) 2014-01-10
WO2010108060A1 (en) 2010-09-23
CA2756047C (en) 2016-04-26
EA022569B1 (ru) 2016-01-29
CN102368904A (zh) 2012-03-07
BRPI1014529A2 (pt) 2015-08-25
AU2010226476B2 (en) 2013-02-07
WO2010108060A8 (en) 2011-12-29
CL2011002302A1 (es) 2012-06-22
EA201171150A1 (ru) 2012-03-30
IL214887A0 (en) 2011-11-30
EP2408299A4 (en) 2012-08-15
IL214887A (en) 2015-09-24
CN102368904B (zh) 2014-03-26
EP2408299B1 (en) 2013-10-23
US20110305646A1 (en) 2011-12-15
CA2756047A1 (en) 2010-09-23
KR20120014553A (ko) 2012-02-17
EP2408299A1 (en) 2012-01-25
US20180360791A1 (en) 2018-12-20
AU2010226476A1 (en) 2011-09-22
JP2012521351A (ja) 2012-09-13
KR101506369B1 (ko) 2015-03-30
MX2011009781A (es) 2011-10-17
PL2408299T3 (pl) 2014-03-31

Similar Documents

Publication Publication Date Title
JP5992324B2 (ja) 脂肪酸モノグリセリド組成物
EP2391344B1 (en) Compositions for nail and skin treatment
CA2888853C (en) Topical steroid composition and method
JP6487949B2 (ja) 局所用コルチコステロイド組成物
US10251885B2 (en) Azole antifungal compositions
CN101641082A (zh) 用于向皮肤释放药物的形成表膜的液体制剂
WO2000053186A1 (en) Topical compositions containing a combination of an antifungal agent and a steroidal antiinflammatory agent
US20160213690A1 (en) Compositions and methods for the treatment of skin diseases
US20190358160A1 (en) Sub-micron emulsions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121018

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131213

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140313

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140320

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160609

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160817

R150 Certificate of patent or registration of utility model

Ref document number: 5992324

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250